LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM
$32,121,523
| Recipient | CERUS CORPORATION UEI KJJQRRLY2FL5 |
|---|---|
| Award ID | 75A50124C00046 |
| Award amount | $32,121,523 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | 6505 |
| Start date | Sep 30, 2024 |
| End date | Sep 30, 2029 |
| Place of performance | CONCORD, CA |
| Record updated | Jun 2, 2026 |
View the official award record
More awards won by CERUS CORPORATION
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
Department of Health and Human Services · $185,466,764 · Jun 17, 2016
BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD
Department of Health and Human Services · $11,106,465 · Sep 24, 2020
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids